Sanofi expects FDA decision on Lemtrada in H2

PARIS (Reuters) - Sanofi expects the U.S. Food and Drug Administration to rule on its application for multiple sclerosis treatment Lemtrada by the second half of this year. The injectable drug, chemically known as alemtuzumab, is one of the new pr...

Source: http://health.yahoo.net/news/s/nm/sanofi-expects-fda-decision-on-lemtrada-in-h2

example here as example as an example explained here